Sherlock Biosciences
Latest round
- Series B
Last raised
- Feb 2022
Total raised
- $113M
Investors
- 9
About Sherlock Biosciences
Sherlock Biosciences focuses on developing advanced molecular diagnostics. Founded in 2019, the company is headquartered in Watertown, Massachusetts, US. The co-founders include David Walt, Jonathan Gootenberg, Omar Abudayyeh, and the current CEO is Rahul Dhanda.Sherlock Biosciences specializes in molecular diagnostics, focusing on the rapid and accurate detection of DNA and RNA through its proprietary technologies, SHERLOCK™ and INSPECTR™. These platforms utilize CRISPR and synthetic biology for point-of-need testing, enhancing healthcare accessibility. The company aims to democratize testing, making personalized healthcare solutions feasible across various settings, from remote clinics to home testing. Its client base includes healthcare providers, laboratories, and end-users seeking timely health-related answers.Sherlock Biosciences generates revenue through a direct-to-consumer model and partnerships with healthcare providers and laboratories. The company markets its diagnostic products at varying prices based on testing complexity and capabilities. Clients typically purchase diagnostic kits or subscribe for ongoing access to testing technologies.The acquisition of Sherlock Biosciences by OraSure Technologies Inc. in December 2024 allows OraSure to broaden its diagnostic offerings by incorporating Sherlock's advanced molecular testing platform. This platform is capable of providing rapid, affordable self-tests for sexually transmitted infections and other health conditions. Future product launches and specific geographic expansions are expected to be outlined as part of the integration strategy following this acquisition.
Who invested in Sherlock Biosciences
9 investors across 2 rounds
See all investors in Sherlock Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sherlock Biosciences
Who invested in Sherlock Biosciences?
Sherlock Biosciences has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sherlock Biosciences raised?
Sherlock Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sherlock Biosciences last raise money?
Sherlock Biosciences's most recent round on record is a Series B, in Feb 2022.
What does Sherlock Biosciences do?
Sherlock Biosciences focuses on developing advanced molecular diagnostics.
Where is Sherlock Biosciences headquartered?
Sherlock Biosciences is headquartered in Watertown, US.
Which VCs invest in companies like Sherlock Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sherlock Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sherlock Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.